Reconstructing the nigrostriatal pathway is one of the major challenges in cell replacement therapies for Parkinson's disease due to the lack of enabling technologies capable of guiding the ...

Axon Enterprise reports Q1 2025 revenue growth of 31%, driven by AI tools & TASER 10. Raised guidance signals confidence despite tariff & macro challenges.

TASER maker Axon Enterprise raised its full-year revenue forecast on Wednesday, banking on sustained demand for its software ...

This explainer outlines how neurons and glial cells coordinate electrical and chemical signals to form complex brain networks ...